ITPC
  • About
    • Vision, Mission, Values
    • History
    • How We Work
    • Our Regions
    • Our Team
    • Our Board
  • Our Work
    • Treatment Education & Research
    • Intellectual Property & Access to Medicines
    • Community Monitoring
    • Building Activism
  • Our Campaigns
    • Be Healthy – Know Your Viral Load
    • Make Medicines Affordable
    • Watch What Matters
  • Resources
  • News
  • Get Involved
  • About
    • Vision, Mission, Values
    • History
    • How We Work
    • Our Regions
    • Our Team
    • Our Board
  • Our Work
    • Treatment Education & Research
    • Intellectual Property & Access to Medicines
    • Community Monitoring
    • Building Activism
  • Our Campaigns
    • Be Healthy – Know Your Viral Load
    • Make Medicines Affordable
    • Watch What Matters
  • Resources
  • News
  • Get Involved
October 20, 2016  |  By ITPCglobal In Latest News

Know Your Viral Load – Free Online Course

Social media icon of Be Healthy - Know your vial load

Is your HIV treatment working?

You have the right to know!

A viral load test is the only sure way to know if your treatment is working.

Whether you are living with HIV or working in the field, this short online course will inform you about the importance of routine viral load testing. You will also learn how to mobilize your community to demand routine viral load tests.

Sign up for the ’Be Healthy – Know Your Viral Load’ online course.

You are Invited

Applications are invited for the online training course ‘Be Healthy – Know Your Viral Load’ (2016) led by the AIDS and Rights Alliance for Southern Africa (ARASA) and the International Treatment Preparedness Coalition (ITPC). The course will inform you why routine viral load testing is critical to health, and how you can mobilize communities to demand the test. The course runs from 7 November to 9 December 2016.

Background

Over the last two decades, treatment coverage has increased, in part, thanks to effective community treatment activism across the globe. Despite these gains, close to half of those in need of treatment still have no access to life-saving medicines. It is also not clear how many people on treatment have access to an essential component of successful treatment – routine viral load (RVL) testing.

As recommended by the World Health Organization (WHO), routine viral load testing is the best way to know if your treatment is working. A test measures the amount of HIV in the blood.. The WHO recommends viral load monitoring six months after starting ART, at 12 months, and routinely every year thereafter.

At present, it is not known how well people living with HIV are doing on various regimens, how many are failing treatment and how many are (or should be) switching to other regimens. All these unknowns beg the question – what is the quality of treatment celebrated by improved treatment coverage?

Upon completing this course, participants will have an understanding of why it is important to monitor HIV treatment. Participants will have the knowledge and tools to urge their governments to make sure the tests are routinely available, accessible and affordable.

Find more details here.

africa free HIV online course rights routine viral load monitoring treatment viral load
Previous StoryBlatant manipulation: overpricing essential medicines
Next StoryBrazil to use dolutegravir in first-line HIV treatment

Related Articles

  • 19388320_1553381298036270_8135352274504053404_o
    Regional Activist Meeting Starts Demand Creation for Differentiated Models of ART Delivery
  • Patient and doctor
    Should Antiretroviral Therapy be Offered the Same Day as Diagnosis?

no replies

Leave your comment Cancel Reply

(will not be shared)

Latest blog posts

  • jias cover photo
    Advocates Publish Commentary on Expanding Treatment Access for Viral Hepatitis C
  • differentiated service delivery
    Why Communities Must Be at the Center of Differentiated Service Delivery
  • ITPC 2018 PreConf Announcement-for website
    Save the Date: Join ITPC at the Community Activist Summit at AIDS 2018
  • PrEP training LATCA group photo
    How ITPC is Helping Countries Create Demand for PrEP
  • Wame Mosime FCAA 2017 domestic funding panel
    Civil Society Must Participate in Domestic Funding Dialogues – Here’s How

Archives

Categories

  • Commentaries
  • Latest News
  • Our Blog
  • Press

Sign up for our Newsletter

Keywords

access to medicines activists advocacy africa aids ARASA civil society communities community community system strengthening Community Treatment Observatory differentiated models of care dolutegravir DTG global fund HCV HIV HIV treatment human rights IAS ICASA India intellectual property ITPC ITPC MENA key population key populations make medicines affordable malawi Othoman Mellouk people living with HIV programs protest RCTO-WA rights routine viral load monitoring Solange Baptiste statement TB training treatment treatment education UN West Africa WHO

ABOUT US

  • Vision, Mission AND Values
  • HISTORY
  • HOW WE WORK
  • Our Team
  • Contact

OUR WORK

  • Treatment Education & ResearcH
  • Intellectual Property & Access to MedicincE
  • Health Financing & AccountabiliTY
  • Building ActivisM

CONNECT WITH ITPC

  • Great news from @DNDi!71 million people stand to benefit from reduced price treatment for #HepC!Read it here: https://t.co/paFOGXIzTR
    April 13, 2018
  • RT @JRatevosian: New @HealthGAP report on impact of HIV funding cuts to Mozambique, South Africa, Cameroon. It's deadly. More funding nee…
    April 11, 2018
  • Treatment advocates outline how we can use what we've learned from the #HIV examples to expand access to #HCV direc… https://t.co/AF3EDg4Il0
    April 11, 2018

Find us elsewhere

Copyright ©2017 ITPC